| Molecule Type | heteromolecule |
| Residue Name (RNME) | ZQ10 |
| Formula | C17H19N3 |
| IUPAC InChI Key | GUYMQGYZONYVMZ-WMCAAGNKSA-N |
| IUPAC InChI | InChI=1S/C17H20N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,14,16H,9-12H2,1H3/t14?,16-/m0/s1 |
| IUPAC Name | |
| Common Name | (R)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine |
| Canonical SMILES (Daylight) | CN1C[C@@H]2N(CC1)C1=[N]=CC=C[C@@H]1Cc1c2cccc1 |
| Number of atoms | 39 |
| Net Charge | 0 |
| Forcefield | multiple |
| Molecule ID | 1397687 |
| ChemSpider ID | 2342167 |
| ChEMBL ID | 608847 |
| Clinial Phase (ChEMBL) | 4 |
| Visibility | Public |
| Molecule Tags |
Generating ...
Generating ...
Generating ...
No charge assignments available. Use the button above to use OFraMP fragment-based charge assignment.
Click table to toggle details.
| Processing Stage | Template | Semi-Empirical QM (QM0) | DFT QM (QM1) | DFT Hessian QM (QM2) | |
|---|---|---|---|---|---|
| Calculation | None | Energy Minization | Energy Minization | Hessian | |
| Level of Theory | None | Semi-Empirical / SCF | DFT (ωB97X/6-31G*) | DFT (ωB97X/6-31G*) | |
| Default Size Limit (Atoms) | 2000 | 500 | 50 | 40 | |
| Content of MD Topology | |||||
| Charges Derived From | None | MOPAC | Merz-Singh-Kollman | Merz-Singh-Kollman | |
| Geometry | User Provided | Optimized | Optimized | Optimized | |
| Non-Bonded Interactions | Bonds | Rule Based: Parameters are asigned from existing parameters with a set of rules based on atom types and geometry. | Hessian Based: Force constant are calculated from the QM potential. New parameters are created when no suitable parameters exists. | ||
| Angles | |||||
| Dihedrals | |||||
| Current Processing State | Completed |
| Total Processing Time | 7:52:05 (hh:mm:ss) |
Access to this feature is currently restricted
The maximum QM level is computed using the ATB Pipeline atom limits but can be manually increased on a case by case basis.
Access to this feature is currently restricted